1. Brigham and Women’s Hospital Heart and Vascular Center, Harvard Medical School, Boston, MA (B.E.P, D.L.B., R.P.G.).
2. Université de Paris, AP-HP (Assistance Publique-Hôpitaux de Paris), Hôpital Bichat, FACT (French Alliance for Cardiovascular Trials), INSERM U-1148, France (Ph.G.S.).
3. Department of Medicine, University of Maryland School of Medicine, Baltimore (M.M.).
4. Utah Lipid Center, Salt Lake City (E.A.B.).
5. Office of Health Promotion and Disease Prevention, Department of Medicine, Emory University School of Medicine, Atlanta, GA (T.A.J.).
6. Amarin Pharma, Inc (Amarin), Bridgewater, NJ (S.B.K., R.A.J., L.J., R.T.D., C.G.).
7. Baim Clinical Research Institute, Boston, MA (C.M.G., D.P.).
8. David Geffen School of Medicine, Lundquist Institute, Torrance, CA (M.J.B.).
9. Montreal Heart Institute, Université de Montréal, Montreal, QC, Canada (J.-C.T.).
10. Division of Cardiac Surgery, St Michael’s Hospital, University of Toronto, ON, Canada (S.V.).
11. Department of Medicine, Baylor College of Medicine, and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX (C.M.B.).